Concepedia

Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults

Martin A. Katzman, Gregory W. Mattingly, Larry J. Klassen, Marc Cataldo, Graeme Donnelly

Journal of Clinical Psychopharmacology · 2020 · 11 citations · 17 references

DOIFull text

Open access

Abstract

Our data indicate that PRC-063 can be taken with or without food or by sprinkling capsule contents on food.

References

17

Development of a New Once-a-Day Formulation of Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder

James M. Swanson, Suneel Gupta, Andrew Lam et al. · Archives of General Psychiatry · 2003 · 245 citations

Characteristics and Motives of College Students Who Engage in Nonmedical Use of Methylphenidate

Robert L. DuPont, John J. Coleman, Richard H. Bucher et al. · American Journal on Addictions · 2008 · 167 citations

A Comparison of Morning-Only and Morning/Late Afternoon Adderall to Morning-Only, Twice-Daily, and Three Times-Daily Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder

William E. Pelham, Elizabeth M. Gnagy, Andrea M. Chronis et al. · PEDIATRICS · 1999 · 137 citations

A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder.

Margaret Steele, Margaret D. Weiss, James M. Swanson et al. · PubMed · 2006 · 130 citations

Methylphenidate Hydrochloride Given With or Before Breakfast: II. Effects on Plasma Concentration of Methylphenidate and Ritalinic Acid

Ying-Pui M. Chan, James M. Swanson, Steven S. Soldin et al. · PEDIATRICS · 1983 · 114 citations · Full text

, , +13